By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Phoenix Molecular Designs 

125-887 Great Northern Way
Discovery Parks
Vancouver  British Columbia  V5T 4T5  Canada
Phone: 1-604-674-1796 96 ext 43700 Fax: n/a


PhoenixMD is a privately-held biopharmaceutical company designing precise cancer therapeutics and companion diagnostics by targeting kinases, a class of highly druggable enzymes to treat a wide range of oncology indications. PhoenixMD is focused on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. Due to its emerging leadership in kinase inhibition, PhoenixMD has entered into partnerships with well-recognized academic and non-profit institutions such as the National Cancer Institute (NIH), University of Florida, Kyushu University, Mayo Clinic, and University of Hawaii Comprehensive Cancer Center. PhoenixMD is headquartered in Vancouver, British Columbia Canada with U.S. operations in San Diego, CA.




Founder and CEO: Sandra Dunn

CFO: Dave Matthews

CBO: Hooshmand Sheshbaradaran

COO: Aarthi Jayanthan

CTO: John Van Drie

CSO: Grace Furman

Key Statistics

Ownership: Private

Web Site: Phoenix Molecular Designs

Company News